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Hepatitis C virus (HCV) core is a viral structural protein; it also participates in some cellular processes, including transcriptional
regulation. However, the mechanisms of core-mediated transcriptional regulation remain poorly understood. Oncogenic virus proteins often
target p300/CBP, a known co-activator of a wide variety of transcription factors, to regulate the expression of cellular and viral genes. Here
we demonstrate, for the first time, that HCV core protein interacts with p300/CBP and enhances both its acetyl-transferase and transcriptional
activities. In addition, we demonstrate that nuclear core protein activates the NH2-terminal transcription activation domain (TAD) of NF-AT1
in a p300/CBP-dependent manner. We propose a model in which core protein regulates the co-activation function of p300/CBP and activates
NF-AT1, and probably other p300/CBP-regulated transcription factors, by a novel mechanism involving the regulation of the acetylation state
of histones and/or components of the transcriptional machinery.
D 2004 Elsevier Inc. All rights reserved.
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Hepatitis C virus (HCV) infection is the most frequent
cause of chronic liver disease in Western countries and 20–
30% of these patients will develop cirrhosis with the risk of
hepatocellular carcinoma. The genome of HCV is composed
of a positive-stranded RNA of 9.6 kb encoding a poly-
protein, of approximately 3010 amino acids, which is
processed by viral and cellular proteases to render 10
proteins (Suzuki et al., 1999). HCV core protein spans the
first 191 amino acids of the polyprotein (Lai and Ware,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: mlopez.hlpr@salud.madrid.org (M. Lo´pez-Cabrera).2000). This immature core protein is further processed at its
COOH-terminal region to render the mature form of 173
amino acids, which shapes the viral nucleocapsid (Yasui
et al., 1998). Analysis of the subcellular localization of core
protein has provided interesting but discrepant results. It has
been shown that immature (1–191) and mature (1–173) core
proteins localize in the cytoplasm, associated with endo-
plasmic reticulum, mitochondria and/or lipid droplets
(Barba et al., 1997; Liu et al., 1997; Marusawa et al.,
1999; Okuda et al., 2002). In addition, other authors have
also described a nuclear localization of the mature and
COOH-terminal truncated forms of core protein (Sabile
et al., 1999; Watashi et al., 2001; Yamanaka et al., 2002b;
Yasui et al., 1998). There are three nuclear localization
signals in the NH2-terminal region of core protein that could
be involved in nuclear translocation (Chang et al., 1994). On04) 120–130
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core appears to be responsible for its cytoplasmic retention
(Liu et al., 1997). In some instances, the function of core
and its subcellular localization have been associated
(Watashi et al., 2001; Yamanaka et al., 2002a).
Besides its structural function, core protein also regulates
different cellular processes. In this context, it has been
shown that core protein expression activates several signal
transduction pathways, leading to activation of transcription
factors such as Elk-1, AP1, Sp1, and Egr-1 (Giambartolomei
et al., 2001; Kato et al., 2000; Lee et al., 2001; Shrivastava
et al., 1998). Other transcription factors, such as p53 and
RXR, are activated by core via mechanisms involving
protein–protein interactions (Otsuka et al., 2000; Tsutsumi
et al., 2002). Modulation of these and other cellular
components by core protein alters the gene expression
pattern and affects important cellular processes, including
apoptosis, cell growth, and transformation (Cho et al., 2001;
Hahn et al., 2000; Machida et al., 2001; Moriya et al., 1998;
Ray et al., 1998, 2000; Ruggieri et al., 1997; Zhu et al.,
1998).
Specific transcription involves the assembly of a multi-
protein complex at the gene enhancer/promoter regions,
which is composed of specific transcription factors, general
transcription machinery and co-activators such as p300/CBP
among others. p300/CBP functions as a bridge due to its
ability to interact both with transcription factors and the
basal transcription machinery (Chan and La-Thangue, 2001;
Goodman and Smolik, 2000; Shikama et al., 1997). In
addition, p300/CBP has histone acetyltransferase activity,
which results in relaxation of chromatin structure to
facilitate the transcription process (Chan and La-Thangue,
2001). More recently, it has been described that other
proteins involved in transcription may also be targets of this
acetyltransferase activity (Barlev et al., 2001; Boyes et al.,
1998; Imhof et al., 1997; Lu et al., 2003; Martinez-Balbas et
al., 2000). Many regulatory proteins of oncogenic viruses
target p300/CBP to control the expression of viral and
cellular genes (Goodman and Smolik, 2000); however, this
mechanism of transcriptional regulation has not been
explored so far for HCV core protein.
Although HCV is mainly hepatotropic, it has been shown
that this virus may also infect cells of the immune system
(Lerat et al., 1998; Sung et al., 2003). Thus, it is conceivable
that HCV may also induce in these cells the expression of
molecules involved in the immune and inflammatory
responses. In this regard, it has been shown that core protein
activates the IL-2 promoter and nuclear factor of activated T
cells (NF-AT)-dependent transcription in T lymphocytes
(Bergqvist and Rice, 2001), by a mechanism involving
cytosolic calcium mobilization and requiring the C-terminal
hydrophobic portion of core (Bergqvist et al., 2003).
NF-AT is a family of transcription factors that includes
four related members, NF-AT 1–4. In resting cells, NF-AT
proteins are phosphorylated in the NF-AT homology region
and retained in the cytoplasm. When cells are activated bycalcium mobilization stimuli, the calcium/calmodulin-
dependent phosphatase calcineurine is activated and
dephosphorylates NF-AT proteins (Rao et al., 1997). Then,
NF-AT proteins translocate to the nucleus where they bind
to their specific DNA sequences either alone or coopera-
tively with transcription factors of the AP-1 family to form
composite NF-AT:AP-1 sites (Rao et al., 1997). Once NF-
AT proteins have targeted their recognition DNA sequen-
ces, they are further functionally regulated by interactions
with transcriptional co-activators and by posttranslational
modifications (Avots et al., 1999; Garcı´a-Rodrı´guez and
Rao, 1998, 2000; San-Antonio et al., 2002).
NF-AT1 is the founding member of the NF-AT family
and is expressed in several cells of the immune system as
well as in other nonimmune tissues (Rao et al., 1997). In
addition, NF-AT1 is the only family member that is
expressed in resting T lymphocytes (Lyakh et al., 1997). It
contains a strong acidic transcription activation domain
(TAD) in the first 100 amino acids of the protein, not
conserved in other family members (Rao et al., 1997),
which is bound and regulated by the co-activator p300/CBP
(Garcı´a-Rodrı´guez and Rao, 1998).
The aim of this study was to determine whether HCV
core was a p300/CBP-regulating protein. Herein, we show
that nuclear core protein interacts with p300/CBP, regulates
both its transcriptional and histone acetyltransferase activi-
ties, and cooperates with calcium-mobilizing stimuli to
further induce NF-AT-mediated transcription and the acti-
vity of NF-AT1-TAD, apparently through the activation of
p300/CBP function.Results
Direct interaction of core protein with the co-activator
p300/CBP
The co-activators p300 and CBP are highly related
proteins that present conserved domains and functions, thus
hereafter they will be described as p300/CBP, unless
otherwise specified. To determine whether core protein
interacts with p300/CBP, a GST-based pull-down assay
was performed. The fusion protein GST-core 1–191, but not
GST, interacted with endogenous p300 from a cellular lysate
of HEK293 cells (Fig. 1A). To study the in vivo interaction
of these proteins, HEK293 cells were co-transfected with the
expression vector pEF-core 1–153, encoding nuclear core
protein (data not shown), along with pCI-Flag-p300, encod-
ing Flag-tagged p300, or the control empty vector. Lysates
from transfected cells were immunoprecipitated using an
anti-p300 mAb and immunoblotted with anti-core or anti-
Flag mAbs. The amount of core protein in the precipitates
increased dramatically when cells were co-transfected with
both expression plasmids (Fig 1B).
To identify the region of p300/CBP involved in the
interaction with core protein and to determine whether the
Fig. 1. Direct interaction of core protein with the co-activator p300/CBP. (A) Pull down assay with GST-core 1–191 or GST and a cellular lysate of HEK293
cells. Bound proteins were subjected to Western blot analysis using an anti-p300 mAb. Coomassie brilliant blue staining of 1/10 of the GST proteins used
shows full-length and degradation products of the chimeric protein (bottom). (B) Cellular lysates of HEK293 cells co-transfected with 5 Ag of pEF-core 1–153
and 5 Ag of pCI-Flag-p300 or a control vector were immunoprecipitated with an anti-p300 mAb. Immunoprecipitates and cellular lysates were analyzed using
anti-core mAb and anti-Flag M2 mAb. (C) Pull-down assay with different GST-CBP constructs and in vitro translated 35S-labeled core protein 1–191 (top).
One microliter of 35S-labeled core protein was run as a control (input). Coomassie brilliant blue staining shows 1/10 of the GST proteins used (middle).
Schematic representation of the CBP constructs employed and summary of the core-binding activity observed (bottom). p300/CBP domains: RID, nuclear
hormone receptors interaction domain; CH1/2/3, cysteine/histidine rich domains 1/2/3; KIX, kinase inducible domain/CREB-binding domain; Br,
bromodomain; HAT, histone acetyltransferase domain.
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was performed, employing different GST-CBP constructs
and in vitro-translated 35S-core 1–191 protein. GST-fused
sequences 1098–1877, 1098–1620, and 1679–1858 of CBP
interacted with 35S-core 1–191, whereas no interaction was
observed with the NH2-terminal fragment of CBP spanning
amino acids 1 to 1099 (Fig. 1C). This result suggests that
the core–CBP interaction is direct. However, the possibility
that a protein of reticulocyte lysate, employed for in vitro
translation, is mediating the interaction cannot be excluded.Sequence alignment of p300 and CBP showed that the
regions of CBP involved in the interaction with core
protein are highly conserved in p300 protein (data not
shown).
Core protein induces the transcriptional and histone
acetyltransferase activities of p300/CBP
The transcriptional activity of the co-activator p300/CBP
may be studied by the Gal4 reporter system using a chimeric
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whether the core-p300/CBP interaction affected the tran-
scriptional activity of the co-activator, Jurkat cells were co-
transfected with the reporter plasmid pGal4-Luc along with
the expression vectors pGal4-CBP and pEF-core 1–153, or
the control plasmids. Co-expression of nuclear core protein
increased the transcriptional activity of Gal4-CBP, with
activations up to fivefold over the values obtained in the
absence of the viral protein (Fig. 2A). These results suggest
that nuclear core protein interacts with p300/CBP and
induces its transcriptional activity.
Given that the region of p300/CBP that interacted with
core contained the histone acetyltransferase domain (HAT)
(Fig. 1C), the effect of core protein on the HAT activity
was analyzed. To this end, HEK293 cells were co-
transfected with the expression vectors pCI-Flag-p300
and pEF-core 1–153 or the control empty vector pEF1a,
and then Flag-p300 was immunoprecipitated with anti-
Flag mAb and used for in vitro acetylation assay. AsFig. 2. Core protein induces the transcriptional and histone acetyltransferase
activities of p300/CBP. (A) Jurkat cells were co-transfected with 0.5 Ag of
pGAL4-Luc along with 1 Ag of either pGal4-CBP or pRSV-Gal4-DBD and
2 Ag of pEF-core 1–153 or pEF1a. Luciferase activity is represented as
mean fold induction over the value obtained in cells transfected with pRSV-
Gal4-DBD and pEF1a and only the values of pGal4-CBP-transfected cells
are shown. Values shown in this and following luciferase activity figures
represent the mean fold induction F SE of at least three independent
experiments. (B) Cellular lysates of HEK293 cells co-transfected with 5 Ag
of pCI-Flag-p300 and 5 Ag of either pEF-core 1–153 or pEF1a were
immnunoprecipitated with anti-Flag M2 mAb and immunoprecipitates were
either employed in in vitro acetylation assays along with purified histones
and [14C]-acetyl coenzyme A (top) or subjected to Western blot analysis
using an anti-Flag M2 mAb (bottom).shown in Fig. 2B, the ability of Flag-p300 to acetylate
histones was increased when core 1–153 was co-
expressed. Similar levels of Flag-p300 were immunopre-
cipitated both in the presence and absence of core protein
(lower panel).
Nuclear forms of core protein induce NF-AT-dependent
transcription
The ability of core protein to induce the IL-2 promoter
in cooperation with different stimuli is abolished by
deletion of its COOH-terminal domain (Bergqvist and
Rice, 2001), which suggests that core function is dependent
of its subcellular localization. To investigate whether this
domain of core was required for cooperative activation of
NF-AT-dependent transcription, Jurkat cells were co-trans-
fected with pNF-AT-Luc, containing three copies of the
composite NF-AT/AP-1 site of the human IL-2 enhancer
element, along with expression vectors coding for full-
length core (pEF-core 1–191) or COOH-terminal truncated
core proteins (pEF-core 1–173 and pEF-core 1–153),
which localize predominantly in the cytoplasmic extract
and in the nuclear insoluble fraction, respectively (data not
shown). The transfected cells were stimulated either with
PMA, to activate only the AP-1 element of the composite
NF-AT/AP-1 site, or with PMA plus calcium ionophore
(hereafter PMA + Io), which provides a full stimulus for
this composite site. As expected, PMA + Io induced the
reporter plasmid pNF-AT-Luc up to 30-fold, whereas PMA
alone was not sufficient to activate this construct (Fig 3A).
Only core protein 1–191 cooperated with PMA treatment,
with activations of eight- to ninefold. In contrast, both full-
length and truncated core proteins (core 1–173 and core 1–
153) exerted a cooperative effect with PMA + Io in the
activation of the NF-AT enhancer (Fig. 3A). No effect of
core protein was observed in the absence of cellular
activation (data not shown). In summary, these results
indicate that nuclear accumulation of core protein,
observed even in core 1–191-transfected cells, synergize
with PMA + Io to further induce NF-AT-dependent
transcription.
To analyze whether core protein was able to induce the
NF-AT1 transactivation domain (TAD) activity once this
factor had targeted its recognition sequences, a Gal4-derived
reporter system was used. Jurkat cells were co-transfected
with the chimeric vectors pGal4-NF-AT1 (1–415), pGal4-
NF-AT1 (1–171), or the parental vector pRSV-Gal4-DBD,
along with the reporter plasmid pGal4-Luc and either pEF-
core 1–191 or the control vector pEF1a. Both chimeric
proteins Gal4-NF-AT1 (1–415) and (1–171) contained the
NH2-terminal TAD of NF-AT1 and activated the reporter
plasmid pGal4-Luc (Fig. 3B). As expected, core 1–191 did
not stimulate transcription when co-transfected with the
control plasmid pRSV-Gal4-DBD (Fig. 3B). In contrast,
the transcription of pGal4-Luc was induced by the full-
length core protein when co-transfected with both Gal4-
Fig. 3. Nuclear forms of core protein induce NF-AT-dependent transcription. (A) Jurkat cells were transfected with 1 Ag of pNF-AT-Luc along with 2 Ag of
pEF-core 1–191, pEF-core 1–173, pEF-core 1–153, or the empty vector pEF1a. Then, cells were either left untreated or stimulated with PMA or PMA/Io.
Luciferase activity is represented as mean fold induction over the value obtained in untreated cells transfected with pEF1a. (B) Jurkat cells were co-transfected
with 0.5 Ag of pGAL4-Luc along with 1 Ag of either pGal4-NF-AT1 1–415, pGal4-NF-AT1 1–171 or pRSV-Gal4-DBD, and 2 Ag of pEF-core 1–191 or pEF1a.
Luciferase activity is represented as mean fold induction over the value obtained in cells transfected with pRSV-Gal4-DBD and pEF1a. (C) Luciferase assay
similar to that described in B in which expression vectors employed were pGal4-NF-AT1 1–171 and pEF-core 1–191, pEF-core 1–173, pEF-core 1–153, or
pEF1a. The luciferase activity is represented as mean fold induction by core proteins over the value obtained in cells transfected with pGal4-NF-AT1 1–171
and pEF1a. *P b 0.05, by using repeated measures ANOVA test. (D) Luciferase assay similar to that described in C in which expression vectors employed
were pGal4-NF-AT1 1–171 and pEF-core 1–153 or pEF-core 1–153-ER. **P b 0.05, by using paired t test. The subcellular distribution of core 1–153 and core
153-ER proteins in HEK293 cells is also shown. (E) Jurkat cells were co-transfected with 0.5 Ag of pGAL4-Luc along with 1 Ag of pGal4-NF-AT1 1–171, 2 Ag
of either pEF-core 1–153 or pEF1a, and 2 Ag of either pE1A or the empty control vector. Luciferase activity is represented as mean fold induction by core
protein over the values obtained in cells transfected with pGal4-NF-AT1 1–171 and pEF1a F E1A.
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was able to induce the NF-AT1-TAD activity (Fig. 3B).
Interestingly, when the truncated forms of core (1–173 and
1–153) were included in the Gal4 reporter assays, statisti-
cally significant higher transactivation abilities of these
mutants, compared with core 1–191, were observed (Fig.
3C). In addition, a construct containing core 1–153 fused
to an endoplasmic reticulum signal peptide (core 1–153-
ER), which showed a partial decrease of nuclear accumu-
lation, displayed a statistically significant parallel reduction
of its ability to induce the NF-AT1-TAD (Fig. 3D). To
analyze whether the effect of nuclear core protein on NF-
AT1 transcription depended on p300/CBP function, the
Gal4 reporter assay was performed in the presence of the
p300/CBP-inhibiting adenoviral protein E1A. As shown in
Fig. 3E, E1A protein inhibited the core-protein-mediated
induction of Gal4-NF-AT1 (1–171) transcriptional activity,
suggesting that p300/CBP might mediate transactivation
function of core.Core protein interacts indirectly with the NH2-terminal
transactivation domain of NF-AT1
To analyze whether core protein was able to interact with
the NH2-terminal transactivation domain of NF-AT1 (NF-
AT1-TAD), a GST-based pull-down assay was performed.
HEK293 cells were transfected with pEF-core 1–191 and
cellular lysates were used in pull-down assays with different
HA-tagged NF-AT1 fragments fused to GST. As shown in
Fig. 4A, core protein interacted with the first 68 amino
acids of NF-AT1, which are located within the NH2-
terminal TAD of this transcription factor. No interaction
was observed when the control proteins GST or GST-HA
were employed in the pull-down assay. A similar binding
was observed when the pull-down assay was performed
with GST-core 1–191 or 1–153 constructs and cellular
lysates of HEK293 cells transfected with pEF-HA-NF-AT1
(1–384) (Fig. 4B). To determine whether core–NF-AT1
interaction was direct, a pull-down assay was performed
Fig. 4. Core protein interacts indirectly with the NH2-terminal transactivation domain of NF-AT1. (A) Pull-down assays using different GST-HA-NF-AT1
constructs and cellular lysates of HEK293 cells transfected with pEF-core 1–191. Coomassie brilliant blue staining shows 1/10 of the GST proteins used
(bottom). (B) Pull-down assay in which GST-core 1–191 and 1–153 were assayed to bind to HA-NF-AT1 1–384 expressed in HEK293 cells. (C) Pull-down
assay with GST-HA-NFAT1 1–384 or GST and in vitro translated 35S-labeled core protein 1–191, either in the presence or absence of the cross-linker DSP. One
microliter of 35S-labeled core protein was run as a control (input).
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GST-NF-AT1 (1–384). As shown in Fig. 4C, in vitro-
translated core protein did not bind to NF-AT1 unless the
binding was forced in the presence of the thiol-cleavable
cross-linker DSP. In agreement with these results, the binding
of core to NF-AT1 could not be observed in vivo by co-
immunoprecipitation assays (data not shown). Taken as a
whole, these results suggested that the induction of the
transcriptional activity NF-AT1-TAD by core protein was not
mediated by a direct interaction between these two proteins.
Deacetylases inhibitors induce the NF-AT-dependent
transcription and mask nuclear core protein function
To analyze whether acetylation might regulate NF-
AT1-dependent transcription, the activity of Gal4-NF-AT1
(1–171) was assessed in the presence of increasing
amounts of the deacetylases inhibitor sodium butyrate.
The activity of NF-AT1-TAD increased in a dose-depend-
ent manner by sodium butyrate (Fig. 5A, left panel).
Similar activation of NF-AT1-TAD was observed with
another deacetylases inhibitor, trichostatin A (Fig. 5A,
central panel). In addition, sodium butyrate further induced
the expression of the reporter plasmid pNF-AT-Luc over
the values obtained with PMA + Io stimulation (Fig. 5A,
right panel). These results suggest that NF-AT1-dependent
transcription is regulated by acetylation of histones and/or
components of the transcriptional machinery.Interestingly, when the effect of nuclear core 1–153 was
analyzed on sodium butyrate-induced Gal4-NF-AT1 (1–171)
activity, a gradual mask of core function was observed as
the concentration of sodium butyrate increased (Fig. 5A,
left panel). It is important to note that the cooperative
effect of core and sodium butyrate in the activation of NF-
AT1-TAD was synergistic at low concentration of the
inhibitor (0.5mM) and tended to be additive as the
concentration of sodium butyrate increased. In addition,
core 1–153 hardly increased TSA-induced Gal4-NF-AT1
(1–171) activity (Fig. 5A, central panel) or the expression
of pNF-AT-Luc induced with PMA + Io and sodium
butyrate (Fig. 5A, right panel). To rule out that the
apparent loss of core function was due to a reduction of
core protein expression or to a change in its subcellular
localization, Jurkat cells were transfected with pEF-core 1–
153 and treated with sodium butyrate. Similar expression
levels and subcellular localization of core 1–153 were
observed both with and without sodium butyrate (data not
shown). In addition, core–CBP interaction was maintained
in the presence of sodium butyrate and only a marginal
decrease in core–NF-AT1 interaction was observed, which
would not explain the mask of core protein function by
deacetylase inhibitors (Fig. 5B). Interestingly, the coopera-
tive activity of PMA and core 1–191 was not blocked by
sodium butyrate (Fig. 5C), suggesting that the masking
effect of the deacetylases inhibitors was specific for the
nuclear function of core. These results, in addition to those
Fig. 5. Deacetylases inhibitors induce the NF-AT-dependent transcription and mask nuclear core protein function. (A) Jurkat cells were co-transfected with 0.5
Ag of pGAL4-Luc along with 1 Ag of pGal4-NF-AT1 1–171 and 2 Ag of pEF1a or pEF-core 1–153. Cells were either left untreated or stimulated with
increasing amounts of the deacetylases inhibitor sodium butyrate (left) or with another deacetylases inhibitor, trichostatin A (TSA) (middle). Luciferase activity
is represented as mean fold induction over the value obtained in untreated cells. Jurkat cells were also co-transfected with 1 Ag of pNF-AT-Luc along with 2 Ag
of the control vector pEF1a or pEF-core 1–153 and either left untreated or stimulated with sodium butyrate and/or PMA/Io (right). Luciferase activity is
represented as mean fold induction over the value obtained in PMA/Io-treated cells. Numbers above the graphics indicate the mean fold induction by core
protein over the values obtained in cells transfected with pGal4-NF-AT1 1–171 and pEF1a F deacetylase inhibitors (left and middle) or the mean fold
induction by core protein over the values obtained in PMA/Io-treated cells F sodium butyrate (right). (B) Pull-down assays using GST-HA-NF-AT1 and GST-
CBP constructs and cellular lysates of HEK293 cells transfected with pEF-core 1–153 and either left untreated or stimulated with 2.5 mM sodium butyrate for
16 h. (C) Jurkat cells were co-transfected with 1 Ag of pNF-AT-Luc along with 2 Ag of pEF-core 1–191 or pEF1a. Cells were either left untreated or stimulated
with sodium butyrate and/or PMA. Luciferase activity is represented as mean fold induction over the value obtained in PMA-treated cells.
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might activate NF-AT1-dependent transcription by activa-
tion of the acetyltransferase activity of p300/CBP, which
results in the acetylation of histones and/or nonidentified
component(s) of the transcriptional complex.Discussion
During the last few years, acetylation has emerged as an
important posttranslational modification to regulate the
function of proteins involved in transcriptional control,
including general and specific transcription factors (Barlev et
al., 2001; Boyes et al., 1998; Imhof et al., 1997; Lu et al.,
2003; Martinez-Balbas et al., 2000). The co-activator
p300/CBP has intrinsic histone acetyltransferase (HAT)
activity, which regulates not only the chromatin structurebut also the activity of numerous proteins of the transcription
complex. It has been shown that the HAT activity of p300/
CBP may be regulated by different cellular factors and by
several viral proteins (Ait-Si-Ali et al., 1998; Deng et al.,
2001; Hamamori et al., 1999; Soutoglou et al., 2001; Zhao
et al., 2003). Therefore, this co-activator should not be
considered as a mere component of the transcriptional
complex, whose only regulatory function is to bridge
specific transcription factors with the basal transcriptional
machinery.
In this study, we demonstrate that HCV core protein
interacts both in vivo and in vitro with p300/CBP and
induces its transcriptional and HAT activities. Furthermore,
we demonstrate that core protein activates the transcriptional
activity of the p300/CBP-regulated protein NF-AT1, once
this transcription factor has targeted its recognition sequen-
ces in the nucleus.
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through a nuclear localization are Tat of HIV-1 (Macia´n and
Rao, 1999) and HBx of HBV (Carretero et al., 2002). These
two viral proteins induce the NF-AT1-TAD activity by a
direct protein–protein interaction. In contrast, the interaction
of core with NF-AT1 did not appear to be direct. In an
attempt to identify the mechanism by which core protein
induces the NF-AT1-TAD activity, we employed the
adenoviral protein E1A 12S, which inhibits the activity of
p300/CBP by interacting with and inhibiting its HAT
activity (Goodman and Smolik, 2000; Hamamori et al.,
1999) and our results suggested that core protein might
enhance NF-AT1 activity by regulating p300/CBP function
and the acetylation state of histones and/or components of
the transcriptional machinery. First, the HAT activity of
p300 is increased in the presence of core protein. And
second, there is a gradual mask of nuclear, but not of
cytoplasmic, core function in the presence of deacetylases
inhibitors. Given that the acetylation state of cellular
proteins is the result of counteracting activities achieved
by acetyltransferases and deacetylases, an increase in
acetylation level may be obtained by stimulating acetyl-
transferases or by inhibiting deacetylases. Therefore, it can
be hypothesized that core protein is not able to further
increase the acetylation level induced by deacetylases
inhibitors, being the effect of core protein masked by these
agents.
In agreement with our results, it has been recently
reported that the expression of core protein induces the
hyperacetylation of p53 at Lys373 and Lys382 residues,
which are specific targets for p300/CBP HAT activity,
leading to enhanced DNA-binding activity of this tran-
scription factor (Kao et al., 2004). Interestingly, the Lys320
residue of p53, which is acetylated by PCAF, is not affected
by core expression (Kao et al., 2004). Our results provide
evidence, for the first time, that both NF-AT-dependent
transcription and NF-AT1-TAD activity are regulated by
acetylation. It would be worth to analyze whether NF-AT1
and/or other proteins involved in the transcriptional complex
built from NF-AT1 could be the target of this posttransla-
tional modification induced by core protein.
Previous studies have shown that core protein synergize
strongly with incomplete stimuli, which do not mobilize
calcium, to activate IL-2 promoter and NF-AT-dependent
transcription in T lymphocytes, suggesting that core protein
may compensate the calcium signal (Bergqvist and Rice,
2001). In agreement with this observation, expression of
full-length core protein induces an increase in the levels of
cytosolic calcium and spontaneous calcium oscillations in
T cells (Bergqvist et al., 2003). The effect of core on
calcium mobilization appears to be mediated by the
insertion of core in the endoplasmic reticulum (ER)
membrane, through its COOH-terminal hydrophobic
sequence, which causes calcium leakage (Bergqvist et al.,
2003). Herein, we show that both full-length and C-
terminal truncated versions of core protein, which do notinteract with the ER membrane, are able to cooperate with
calcium-mobilizing stimuli to further induce NF-AT-
dependent transcription and to increase the activity of
NF-AT1-TAD. We propose a novel mechanism for
activation of NF-AT1, and probably other transcription
factors, by core, involving the interaction of nuclear core
with and activation of the co-activator p300/CBP. Our
results point to core protein as a new p300/CBP HAT-
inducing protein and add new insight to understand the
transcriptional regulation by HCV in the infected cells.Materials and methods
Cell culture and plasmid constructs
The human T lymphoma cell line Jurkat and HEK
(human embryonic kidney) 293 cells were grown as
previously described (Carretero et al., 2002).
The expression vector pEF1a has been previously
described as pcDEF (Zhu et al., 1998). The expression
vectors pEF-core 1–191, 1–173, and 1–153 were generated
by subcloning, into pEF1a, PCR fragments encoding amino
acids 1–191, 1–173, and 1–153 of core protein, respec-
tively, from HCV genotype 1b. The expression vector pEF-
core 1–153-ER was obtained by fusing in COOH-terminus
of core 1–153 the endoplasmic reticulum signal peptide
GWSCIILFLVATATGAHS from vector pEF/myc/ER (Invi-
trogen, The Netherlands). The PCR fragment encoding
amino acids 1 to 191 of core protein was cloned into
pcDNA3.1 vector (Invitrogen), and this vector was
employed for in vitro synthesis of core protein. The
plasmids pGST-core 1–191 and 1–153 were constructed
by subcloning into pGEX-2T (Amersham Bioscience, UK),
fragments coding for core 1–191 or 1–153. The plasmid
pCI-Flag-p300, encoding full-length Flag-tagged p300, and
the vectors pGST-CBP 1–1099, 1098–1877, 1098–1620,
and 1679–1858, coding for the indicated CBP protein
amino acid sequences fused to the GST protein, were kindly
provided by Dra. A. Aranda (Instituto de Investigaciones
Biome´dicas, Madrid, Spain). The plasmid pGal4-CBP,
coding for a human/mouse CBP chimera fused to the
DNA binding domain (DBD) of yeast Gal4 protein, has
been previously described (Chawla et al., 1998). The
expression vector pE1A, encoding the wild-type E1A 12S
adenoviral protein, was kindly provided by Dr. J.C. Lacal
(Instituto de Investigaciones Biome´dicas). The plasmids
pRSVGal4-DBD, pGal4-NF-AT1 1–415, and pGal4-NF-
AT1 1–171 have already been described (Luo et al., 1996)
and were kindly provided by Dr. A. Rao (Harvard Medical
School, Boston, MA). The plasmid pEF-HA-NF-AT1 1–384,
encoding a C-terminal deleted HA-tagged murine NF-AT1,
has been described elsewhere (Carretero et al., 2002). The
plasmids pGST-HA, pGST-HA-NF-AT1 1–68, and pGST-
HA-NF-AT1 1–57 have been previously described (Carre-
tero et al., 2002). The construct pGST-HA-NF-AT1 1–384
M. Go´mez-Gonzalo et al. / Virology 328 (2004) 120–130128was generated by cloning into pGEX-4T-2 (Amersham) a
PCR fragment encoding amino acids 1–384 of murine HA-
tagged NF-AT1. The reporter construct pNF-AT-Luc con-
tains three tandem copies of a composite NF-AT/AP-1
binding site of the human IL-2 promoter fused to the
minimal IL-2 promoter (Durand et al., 1988) and was
provided by Dr. G. Crabtree (Stanford University Medical
School, Stanford, CA). The reporter plasmid pGal4-Luc,
bearing five copies of the Gal4-binding sites upstream of the
luciferase gene, was a kind gift from Dr. R. Perona (Instituto
de Investigaciones Biome´dicas, Madrid, Spain).
Transfection and luciferase assay
Jurkat cells were transfected with the indicated plasmids,
employing Lipofectin (Gibco-BRL, Gaithersburg, MD)
according to manufacturer’s recommendations. At 24 h after
transfection, cells were either left untreated or stimulated
with PMA, Io, sodium butyrate, and/or trichostatin A (TSA)
for 12 h. Then, cells were harvested and cellular extracts
were assayed for luciferase activity using a Lumat LB9501
luminometer (Berthold, Wildbad, Germany).
Nuclear and cytoplasmic extracts
Jurkat cells were transfected, by electroporation, with 40
Ag of expression vector pEF-core 1–191, 1–173, or 1–153
using an electrical pulse of 0.28 kV and 1200 micro-
Faradays (AF). At 36 h after transfection, cells were either
lysed with buffer Laemmli or separated into cytoplasmic
and nuclear soluble fractions, employing the NE-PER
Nuclear and Cytoplasmic Extraction Reagents from Pierce
(Rockford, IL). After extraction of the nuclear soluble
fraction, the remaining insoluble material was resuspended
in Laemmli buffer and it is called nuclear-insoluble fraction.
Purity of the different fractions was determined by checking
in these extracts the presence of the cytoplasmic marker
tubulin and of the nuclear marker Sp1, by Western blot
assay, employing an anti-tubulin monoclonal antibody from
Sigma (St. Louis, MO) and an anti-Sp1 polyclonal antibody
from Santa Cruz (Santa Cruz, CA). The presence of core
protein in the different fractions was determined by Western
blot analysis using an anti-core monoclonal antibody (mAb)
from Affinity BioReagents (Goleen, CO).
HEK293 cells were transfected with 10 Ag of expression
plasmid pEF-core 1–153 or pEF-core 1–153-ER, using
FuGENE 6 transfection reagent (Roche, Mannheim, Ger-
many) and 24 h after transfection separated in subcellular
fractions as described above.
Purification of recombinant proteins and pull-down assays
GST fusion proteins were expressed in E. coli strain
BL21 and purified with glutathione-Sepharose 4B (Amer-
sham Pharmacia Biotech, Uppsala, Sweden) as previously
described (Carretero et al., 2002). Coomassie staining ofthese preparations frequently showed a ladder pattern of
bands of degradation products or incompletely synthesized
polypeptides. Approximately 10 Ag of GST fusion proteins
immobilized on glutathione–Sepharose 4B were incubated
at 4 8C overnight with total cellular extracts from HEK293
cells or transfected HEK293 cells in lysis buffer containing
0.25% NP-40, 150 mM NaCl, 50 mM Tris–HCl pH 7.4, 4
Ag/ml aprotinin, 4 Ag/ml leupeptin, and 2 mM PMSF.
When indicated, transfected HEK293 cells were either left
untreated or stimulated with 2.5mM sodium butyrate for 16
h before lysis. Bound proteins were analyzed by Western
blot using anti-p300 mAb (Oncogene, Boston, MA), anti-
core mAb (Affinity BioReagents), or anti-HA 12CA5 mAb
(Roche). For direct interaction assays, GST proteins were
incubated with 15 Al of in vitro translated 35S-labeled core
protein 1–191, which was synthesized using TnT Coupled
Reticulocyte Lysate Systems (Promega, Madison, USA).
Binding was performed for 2 h at 4 8C in binding buffer
containing 0.25% NP-40, 150 mM NaCl, 50 mM Tris–HCl
pH 7.4, 4 Ag/ml aprotinin, 4 Ag/ml leupeptin and 2 mM
PMSF. When indicated, binding reactions were performed
in the presence of 30 mM thiol-cleavable cross-linker DSP
(dithiobis succinimidyl propionate) from Pierce. After
washing, bound proteins were fractionated by SDS-PAGE.
Radioactive signal was increased by incubating fixed gel
with Amplify reagent (Amersham Pharmacia Biotech) and
visualized by autoradiography.
Co-immunoprecipitation
HEK293 cells were co-transfected with 5 Ag of expres-
sion plasmid pEF-core 1–153 and 5 Ag of expression
plasmids pCI-Flag-p300 or the empty vector, using FuGENE
6 transfection reagent (Roche). Cells were lysed in buffer
containing 150 mM NaCl, 50 mM Tris–HCl pH 7.4, 0.25%
NP-40, 1 mM PMSF, 1 mM EGTA, 1 Ag/ml aprotinin, and 1
Ag/ml leupeptin, and precleared with protein A-Sepharose
(Amersham Pharmacia Biotech). Precleared lysates were
then immunoprecipitated with anti-p300 mAb from Onco-
gene. Bound proteins were separated on a SDS-polyacryla-
mide gel and analyzed by Western blotting using anti-Flag
M2 mAb (Sigma) and anti-core mAb.
Histone acetylation assays
HEK293 cells were co-transfected with 5 Ag of pCI-
Flag-p300 and 5 Ag of pEF-core 1–153 or pEF1a, using
FuGENE 6 transfection reagent. Cells were lysed and
cellular lysates were immunoprecipitated, as described in
the previous section, with an anti-Flag M2 mAb. Immu-
nocomplexes were then resuspended in acetylation buffer
containing 20 mM HEPES pH 7.4, 1 mM DTT, 10 mM
sodium butyrate, 1 Ag histones (type IIA from Sigma) and
0.5 ACi [14C]-acetyl coenzyme A (Amersham Pharmacia
Biotech) and reactions were performed at 37 8C for 1 h.
Then, samples were run in SDS-PAGE. Radioactive signal
M. Go´mez-Gonzalo et al. / Virology 328 (2004) 120–130 129was increased by incubating fixed gel with Amplify
reagent and visualized by autoradiography.Acknowledgments
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